Three consultants resign as FDA advisors over approval of Alzheimer’s drug

https://ift.tt/eA8V8J
Enlarge / The Meals and Drug Administration headquarters in White Oak, Maryland. Getty | Congressional Quarterly Fallout continues from the Meals and Drug Administration’s contentious determination this week to approve Biogen’s Alzheimer’s drug Aduhelm (aducanumab) regardless of a scarcity of efficacy information. Three consultants who sat on an advisory committee for the FDA have now …
Source: https://ift.tt/3pMssab